Mainz Biomed (MYNZ) Debt to Equity (2020 - 2024)
Historic Debt to Equity for Mainz Biomed (MYNZ) over the last 5 years, with Q4 2024 value amounting to $0.17.
- Mainz Biomed's Debt to Equity fell 8870.85% to $0.17 in Q4 2024 from the same period last year, while for Dec 2024 it was $0.17, marking a year-over-year decrease of 8870.85%. This contributed to the annual value of $0.17 for FY2024, which is 8870.85% down from last year.
- As of Q4 2024, Mainz Biomed's Debt to Equity stood at $0.17, which was down 8870.85% from $1.5 recorded in Q4 2023.
- Over the past 5 years, Mainz Biomed's Debt to Equity peaked at $1.5 during Q4 2023, and registered a low of -$0.01 during Q4 2020.
- For the 5-year period, Mainz Biomed's Debt to Equity averaged around $0.37, with its median value being $0.17 (2024).
- Its Debt to Equity has fluctuated over the past 5 years, first plummeted by 9892.57% in 2022, then surged by 6540363.47% in 2023.
- Quarter analysis of 5 years shows Mainz Biomed's Debt to Equity stood at -$0.01 in 2020, then surged by 2475.28% to $0.21 in 2021, then tumbled by 98.93% to $0.0 in 2022, then soared by 65403.63% to $1.5 in 2023, then plummeted by 88.71% to $0.17 in 2024.
- Its Debt to Equity stands at $0.17 for Q4 2024, versus $1.5 for Q4 2023 and $0.0 for Q4 2022.